Numit Skin Numbing Cream

Numbing Cream
Why Numit?

Numit contains a harmonious combination of lidocaine 2.5% w/w (also called lignocaine) and prilocaine 2.5% w/w. Studies have shown that this combination of local anaesthetics can penetrate the skin and target nerve endings. This helps stop pain signals from starting and spreading1,2.

This creates a skin-numbing effect, so you, or your child can tough it through a range of common minor superficial medical and cosmetic procedures, needles and vaccinations, or other minor procedures. Numit is suitable for infants^, children, adults and the elderly. 

Why Numb It?

Did you know that approximately 85% of all hospital admissions receive IV therapy4? Needles are an unavoidable part of childhood and adult life. However, the associated pain doesn’t have to be. 

Fear of needles can begin with an unpleasant experience and evolve into a lifelong phobia5 creating many stressful situations particularly in those who may require regular injections such as children and adults with diabetes. Fear of needles can lead to patients refusing to adhere to their insulin schedule6 and being generally reluctant to get necessary injections. 

A combination numbing cream can take the pain out of injections and minor procedures, helping to avoid those bad experiences that may contribute to a fear of needles. 

Numit is an easy to use and affordable Australian anaesthetic cream with at least 2 hours of numbing action. 

Waxing, epilation and laser hair removal can also become a less stressful and painful experience with the help of a numbing anaesthetic cream. Tattoos and tattoo removal are less daunting with the help of an anaesthetic skin numbing cream.

Numit Cream

1. NIH. National Cancer Institutes SEER training modules [internet]. 2018 [cited 2018 May 1]. Available from

2. Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of Emla cream. Br J Anaesth 1990; 64(2):173–7.

3. IRI MAT Units June 2020

4. Keogh S, Flynn J, Marsh N, Higgins N, Davies K, Rickard CM. Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey. Int J Nurs Stud 2015; 52(11):1678–85.

5. [accessed Jan 7 2021]

6. Feitosa Alina Coutinho Rodrigues, Sampaio Luciana Nunes, Batista Ana Graciele Lessa, Pinheiro Carla Borges. Frequência de medo de agulhas e impacto de uma abordagem educacional multidisciplinar em gestantes com diabetes. Rev. Bras. Ginecol. Obstet.  [Internet]. 2013  Mar [cited  2021  Jan  07] ;  35( 3 ): 111-116. Available from:

* Price based on online discount pharmacy purchase prices as per June 17, 2020

^Not suitable for premature infants or infants between 0-12 months of age receiving methaemoglobin-inducing agents.